Products
  1. Home
  2. Products
  3. Inhibitors & Activators for IBD Research
Products
Inquiry

* Please note that all of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.

BLU-945

Cat. No.: IBDI-432663

BLU-945 is a potent, highly selective, reversible and orally active epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKIs). BLU-945 can effectively inhibit EGFR with L858R and/or exon 19 deletion mutation, T790M mutation and C797S mutation. BLU-945 can be used for the research of lung cancer including non-small cell lung cancer (NSCLC).

Size (Solid):

Product Details

Target EGFR
Molecular Weight 556.70
Appearance Solid
SMILES CC(C1=CC=C(N2[[email protected]@H]([[email protected]](C2)CS(C)(=O)=O)C)C3=C1C=C(NC4=NC(N5C[[email protected]@H]([[email protected]@H](CC5)OC)F)=NC=C4)N=C3)C
Purity 99.90%

Storage & Handling

Shipping Room temperature in continental US. May vary elsewhere.
Storage Please store the product under the recommended conditions in the Certificate of Analysis.
Regulatory Status This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use.
! For research use only, not intended for any clinical use.
Copyright © Ace Therapeutics. All rights reserved.